Literature DB >> 21574059

Treatment of long bone defects and non-unions: from research to clinical practice.

Arne Berner1, Johannes C Reichert, Michael B Müller, Johannes Zellner, Christian Pfeifer, Thomas Dienstknecht, Michael Nerlich, Scott Sommerville, Ian C Dickinson, Michael A Schütz, Bernd Füchtmeier.   

Abstract

The treatment of long bone defects and non-unions is still a major clinical and socio-economical problem. In addition to the non-operative therapeutic options, such as the application of various forms of electricity, extracorporeal shock wave therapy and ultrasound therapy, which are still in clinical use, several operative treatment methods are available. No consensus guidelines are available and the treatments of such defects differ greatly. Therefore, clinicians and researchers are presently investigating ways to treat large bone defects based on tissue engineering approaches. Tissue engineering strategies for bone regeneration seem to be a promising option in regenerative medicine. Several in vitro and in vivo studies in small and large animal models have been conducted to establish the efficiency of various tissue engineering approaches. Neverthelsss, the literature still lacks controlled studies that compare the different clinical treatment strategies currently in use. However, based on the results obtained so far in diverse animal studies, bone tissue engineering approaches need further validation in more clinically relevant animal models and in clinical pilot studies for the translation of bone tissue engineering approaches into clinical practice.

Entities:  

Mesh:

Year:  2011        PMID: 21574059     DOI: 10.1007/s00441-011-1184-8

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  23 in total

1.  Hollow hydroxyapatite microspheres/chitosan composite as a sustained delivery vehicle for rhBMP-2 in the treatment of bone defects.

Authors:  Ai-Hua Yao; Xu-Dong Li; Long Xiong; Jian-Hua Zeng; Jun Xu; De-Ping Wang
Journal:  J Mater Sci Mater Med       Date:  2015-01-13       Impact factor: 3.896

2.  Delayed minimally invasive injection of allogenic bone marrow stromal cell sheets regenerates large bone defects in an ovine preclinical animal model.

Authors:  Arne Berner; Jan Henkel; Maria A Woodruff; Roland Steck; Michael Nerlich; Michael A Schuetz; Dietmar W Hutmacher
Journal:  Stem Cells Transl Med       Date:  2015-04-01       Impact factor: 6.940

3.  Technical and clinical feasibility of contrast-enhanced ultrasound evaluation of long bone non-infected nonunion healing.

Authors:  Simona Pozza; Armanda De Marchi; Chiara Albertin; Domenico Albano; Ginevra Biino; Domenico Aloj; Luca Maria Sconfienza
Journal:  Radiol Med       Date:  2018-05-05       Impact factor: 3.469

4.  A preclinical large-animal model for the assessment of critical-size load-bearing bone defect reconstruction.

Authors:  David S Sparks; Siamak Saifzadeh; Flavia Medeiros Savi; Constantin E Dlaska; Arne Berner; Jan Henkel; Johannes C Reichert; Martin Wullschleger; Jiongyu Ren; Amaia Cipitria; Jacqui A McGovern; Roland Steck; Michael Wagels; Maria Ann Woodruff; Michael A Schuetz; Dietmar W Hutmacher
Journal:  Nat Protoc       Date:  2020-02-14       Impact factor: 13.491

Review 5.  [Development of CRISPR technology and its application in bone and cartilage tissue engineering].

Authors:  Guo Chen; Du Cheng; Bin Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-12-30

6.  BMP7-overexpressing bone marrow-derived mesenchymal stem cells (BMSCs) are more effective than wild-type BMSCs in healing fractures.

Authors:  Xu Yan; Zhenhua Zhou; Lixin Guo; Zhaochi Zeng; Zhongkai Guo; Qingdong Shao; Weidong Xu
Journal:  Exp Ther Med       Date:  2018-06-21       Impact factor: 2.447

Review 7.  Biomaterial-mediated strategies targeting vascularization for bone repair.

Authors:  José R García; Andrés J García
Journal:  Drug Deliv Transl Res       Date:  2016-04       Impact factor: 4.617

8.  Injectable mineralized microsphere-loaded composite hydrogels for bone repair in a sheep bone defect model.

Authors:  Ganesh C Ingavle; Marissa Gionet-Gonzales; Charlotte E Vorwald; Laurie K Bohannon; Kaitlin Clark; Larry D Galuppo; J Kent Leach
Journal:  Biomaterials       Date:  2019-01-10       Impact factor: 12.479

9.  Cell-based therapies for regenerating bone.

Authors:  S B Goodman
Journal:  Minerva Ortop Traumatol       Date:  2013-04-01

10.  Investigation into the effects of leukemia inhibitory factor on the bone repair capacity of BMSCs-loaded BCP scaffolds in the mouse calvarial bone defect model.

Authors:  Youde Liang; Ruiping Zhou; Xin Liu; Zhikang Liu; Lin You; Chang Chen; Xiaoling Ye
Journal:  J Bioenerg Biomembr       Date:  2021-06-10       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.